. 2025 Aug 23;25:1367. doi: 10.1186/s12903-025-06687-8

Table 5.

Fractal dimension variables, according to pharmacological treatment (N=48)

*Variable*	Mean (±SD)			Contrast test (ANOVA o Kruskal-W)	Effect sizeR²
	Both drugs (n=27)	Pamidronate (n=10)	Zoledronic acid (n=11)	Contrast test (ANOVA o Kruskal-W)	Effect sizeR²
	Both drugs (n=27)	Pamidronate (n=10)	Zoledronic acid (n=11)	*Statistics*	P-value
ROI 1	1.1208 (±0.2737)	1.1339 (±0.1884)	1.0661 (±0.3191)	Z_KW=0.45	.797	.003
*ROI 2*	1.1078 (±0.1943)	1.1682 (±0.2812)	1.0883 (±0.5042)	Z_KW=0.53	.769	.028
*ROI 3 right.*	1.2364 (±0.1746)	1.3262 (±0.2134)	1.2149 (±0.1637)	F=0.34	.319	.050
*ROI 3 left.*	1.2460 (±0.1799)	1.2801 (±0.1468)	1.2046 (±0.1531)	F=1.42	.589	.023
*ROI 4*	1.1399 (±0.1323)	1.1995 (±0.0701)	1.0722 (±0.1231)	F=0.51	.062	.116
*ROI 5*	1.2548 (±0.1145)	1.2779 (±0.0909)	1.2197 (±0.1179)	F=1.61	.480	.032